The differential effects of acetaminophen on lipopolysaccharide induced hyperalgesia in various mouse pain models

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 1, 2008, Pages 121-127

  Seo, Young Jun ^a   Kwon, Min Soo ^a   Choi, Hee Woo ^a   Choi, Seung Min ^a   Nam, Joo Sun ^b   Lee, Jin Koo ^a   Jung, Jun Sub ^a   Park, Soo Hyun ^a   Suh, Hong Won ^a  

^a Hallym University   (South Korea)

^b Korea Drug and Food Administration   (South Korea)

Author keywords

Acetaminophen; Formalin; Glutamate; Intracerebroventricularly; Intrathecally; Lipopolysaccharide; Substance P

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; FORMALDEHYDE; GLUTAMIC ACID; LIPOPOLYSACCHARIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HYPERALGESIA; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; FORMALDEHYDE; GLUTAMIC ACID; HYPERALGESIA; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; INJECTIONS, SUBCUTANEOUS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR; PAIN MEASUREMENT; SUBSTANCE P;

EID: 50649112803     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.06.020     Document Type: Article

References (52)

1. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S., et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 99 (2002) 13926-13931
2. Chen H.S., and Lipton S.A. The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97 (2006) 1611-1626
3. Choi S.S., Lee J.K., and Suh H.W. Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models. Brain Res 7 921 (2001) 233-239
4. Chung K.M., Lee K.C., Song D.K., Huh S.O., Choi M.R., Kim Y.H., et al. Differential modulatory roles of cholera toxin and pertussis toxin in the regulation of pain responses induced by excitatory amino acids administered intrathecally in mice. Brain Res 9 867 (2000) 246-249
5. Coderre T.J., and Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12 (1992) 3665-3670
6. Coderre T.J., Katz J., Vaccarino A.L., and Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52 (1993) 259-285
7. Courade J.P., Caussade F., Martin K., Besse D., Delchambre C., Hanoun N., et al. Effects of acetaminophen on monoaminergic systems in the rat central nervous system. Naunyn Schmiedebergs Arch Pharmacol 364 (2001) 534-537
8. Courade J.P., Chassaing C., Bardin L., Alloui A., and Eschalier A. 5-HT receptor subtypes involved in the spinal antinociceptive effect of acetaminophen in rats. Eur J Pharmacol 432 (2001) 1-7
9. Cridland R.A., and Henry J.L. Comparison of the effects of substance P, neurokinin A, physalaemin and eledoisin in facilitating a nociceptive reflex in the rat. Brain Res 381 (1986) 93-99
10. Fiebich B.L., Lieb K., Hull M., Aicher B., van Ryn J., Pairet M., et al. Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E(2) synthesis in rat microglial cells. Neuropharmacology 39 (2000) 2205-2213
11. Flower R.J., and Vane J.R. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 240 (1972) 410-411
12. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12 (1957) 12-15
13. Hogestatt E.D., Jonsson B.A., Ermund A., Andersson D.A., Bjork H., Alexander J.P., et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 280 (2005) 31405-31412
14. Hunskaar S., and Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30 (1987) 103-114
15. Hunskaar S., Fasmer O.B., and Hole K. Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Methods 14 (1985) 69-76
16. Hunt S.P., and Mantyh P.W. The molecular dynamics of pain control. Nat Rev Neurosci 2 (2001) 83-91
17. Hylden J.L., and Wilcox G.L. Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res 217 (1981) 212-215
18. Johnston I.N., and Westbrook R.F. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia. Behav Brain Res 156 (2005) 75-83
19. Kemper R.H., Spoelstra M.B., Meijler W.J., and Ter Horst G.J. Lipopolysaccharide-induced hyperalgesia of intracranial capsaicin sensitive afferents in conscious rats. Pain 78 (1998) 181-190
20. Libert F., Bonnefont J., Bourinet E., Doucet E., Alloui A., Hamon M., et al. Acetaminophen: a central analgesic drug that involves a spinal tropisetron-sensitive, non-5-HT(3) receptor-mediated effect. Mol Pharmacol 66 (2004) 728-734
21. Lucifora S., Willcockson H.H., Lu C.R., Darstein M., Phend K.D., Valtschanoff J.G., et al. Presynaptic low- and high-affinity kainate receptors in nociceptive spinal afferents. Pain 120 (2006) 97-105
22. Maier S.F., Wiertelak E.P., Martin D., and Watkins L.R. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res 623 (1993) 321-324
23. Mason P. Lipopolysaccharide induces fever and decreases tail flick latency in awake rats. Neurosci Lett 154 (1993) 134-136
24. Matsumoto H., Naraba H., Ueno A., Fujiyoshi T., Murakami M., Kudo I., et al. Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice. Eur J Pharmacol 352 (1998) 47-52
25. Meller S.T., and Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52 (1993) 127-136
26. Miczek K.A., Thompson M.L., and Shuster L. Analgesia following defeat in an aggressive encounter: development of tolerance and changes in opioid receptors. Ann N Y Acad Sci 467 (1986) 14-29
27. Mitchell J.A., and Warner T.D. Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol 128 (1999) 1121-1132
28. Murray C.W., Cowan A., and Larson A.A. Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model. Pain 44 (1991) 179-185
29. Nagy J.I., and Hunt S.P. Fluoride-resistant acid phosphatase-containing neurones in dorsal root ganglia are separate from those containing substance P or somatostatin. Neuroscience 7 (1982) 89-97
30. Ohkubo T., Shibata M., Takahashi H., and Inoki R. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord. J Pharmacol Exp Ther 252 (1990) 1261-1268
31. Padi S.S., and Kulkarni S.K. Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test. Indian J Exp Biol 43 (2005) 53-60
32. Pickering G., Loriot M.A., Libert F., Eschalier A., Beaune P., and Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther 79 (2006) 371-378
33. Raffa R.B., Walker E.A., and Sterious S.N. Opioid receptors and acetaminophen (paracetamol). Eur J Pharmacol 503 (2004) 209-210
34. Satyanarayana P.S., Jain N.K., Singh S., and Kulkarni S.K. Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia. Inflammopharmacology 12 (2004) 57-68
35. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., and Isakson P. Distribution of COX-1 and COX-2 in normal and inflamed tissues. Adv Exp Med Biol 400A (1997) 167-170
36. Skilling S.R., Smullin D.H., Beitz A.J., and Larson A.A. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J Neurochem 51 (1988) 127-132
37. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69 (2000) 145-182
38. Swierkosz T.A., Jordan L., McBride M., McGough K., Devlin J., and Botting R.M. Actions of paracetamol on cyclooxygenases in tissue and cell homogenates of mouse and rabbit. Med Sci Monit 8 (2002) BR496-BR503
39. Tolman E.L., Fuller B.L., Marinan B.A., Capetola R.J., Levinson S.L., and Rosenthale M.E. Tissue selectivity and variability of effects of acetaminophen on arachidonic acid metabolism. Prostaglandins Leukot Med 12 (1983) 347-356
40. Ueno A., Matsumoto H., Naraba H., Ikeda Y., Ushikubi F., Matsuoka T., et al. Major roles of prostanoid receptors IP and EP(3) in endotoxin-induced enhancement of pain perception. Biochem Pharmacol 62 (2001) 157-160
41. Vaccarino A.L., Marek P., and Liebeskind J.C. Stress-induced analgesia prevents the development of the tonic, late phase of pain produced by subcutaneous formalin. Brain Res 14 572 (1992) 250-252
42. Vane J. Towards a better aspirin. Nature 367 (1994) 215-216
43. Vane J.R., and Botting R.M. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47 Suppl 2 (1998) S78-S87
44. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38 (1998) 97-120
45. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2 (2003) 973-985
46. Watkins L.R., Wiertelak E.P., Furness L.E., and Maier S.F. Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids. Brain Res 664 (1994) 17-24
47. Watkins L.R., Wiertelak E.P., Goehler L.E., Mooney-Heiberger K., Martinez J., Furness L., et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res 639 (1994) 283-299
48. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., and Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res 654 (1994) 15-26
49. Wiertelak E.P., Furness L.E., Watkins L.R., and Maier S.F. Illness-induced hyperalgesia is mediated by a spinal NMDA-nitric oxide cascade. Brain Res 664 (1994) 9-16
50. Wiertelak E.P., Smith K.P., Furness L., Mooney-Heiberger K., Mayr T., Maier S.F., et al. Acute and conditioned hyperalgesic responses to illness. Pain 56 (1994) 227-234
51. Wieseler-Frank J., Maier S.F., and Watkins L.R. Central proinflammatory cytokines and pain enhancement. Neurosignals 14 (2005) 166-174
52. Wu K.K. Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol 33 (1995) 179-207